SG44031A1 - Novel glycosphingolipids process for manufacturing the same and the use therefor - Google Patents

Novel glycosphingolipids process for manufacturing the same and the use therefor

Info

Publication number
SG44031A1
SG44031A1 SG1996009529A SG1996009529A SG44031A1 SG 44031 A1 SG44031 A1 SG 44031A1 SG 1996009529 A SG1996009529 A SG 1996009529A SG 1996009529 A SG1996009529 A SG 1996009529A SG 44031 A1 SG44031 A1 SG 44031A1
Authority
SG
Singapore
Prior art keywords
novel
glycosphingolipids
manufacturing
same
sphingoglycolipid
Prior art date
Application number
SG1996009529A
Other languages
English (en)
Inventor
Koji Akimoto
Takenori Natori
Tatsuo Higa
Yasuhiko Koezuka
Teruyuki Sakai
Morita Masahiro
Original Assignee
Kirin Brewery
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery filed Critical Kirin Brewery
Publication of SG44031A1 publication Critical patent/SG44031A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG1996009529A 1991-08-29 1992-04-28 Novel glycosphingolipids process for manufacturing the same and the use therefor SG44031A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3244384A JPH0559081A (ja) 1991-08-29 1991-08-29 新規スフインゴ糖脂質、その製造法および使用

Publications (1)

Publication Number Publication Date
SG44031A1 true SG44031A1 (en) 1997-11-14

Family

ID=17117885

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996009529A SG44031A1 (en) 1991-08-29 1992-04-28 Novel glycosphingolipids process for manufacturing the same and the use therefor

Country Status (18)

Country Link
EP (1) EP0609437B1 (fr)
JP (2) JPH0559081A (fr)
KR (1) KR100220793B1 (fr)
AT (1) ATE181922T1 (fr)
AU (1) AU665536B2 (fr)
CA (1) CA2116442C (fr)
DE (1) DE69229557T2 (fr)
DK (1) DK0609437T3 (fr)
ES (1) ES2134213T3 (fr)
FI (1) FI105189B (fr)
GR (1) GR3030723T3 (fr)
HU (1) HU223839B1 (fr)
NO (1) NO180338C (fr)
PT (1) PT100736B (fr)
SG (1) SG44031A1 (fr)
TW (1) TW197446B (fr)
WO (1) WO1993005055A1 (fr)
ZA (1) ZA923239B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
TW261533B (fr) * 1992-07-16 1995-11-01 Kirin Brewery
KR100281264B1 (ko) * 1992-10-22 2001-02-01 마나배 게이사꾸 신규한 스핀고당 지질 및 그의 사용
JP4020958B2 (ja) * 1993-04-15 2007-12-12 キリンファーマ株式会社 新規スフィンゴ糖脂質およびその使用
TW555562B (en) 1996-12-27 2003-10-01 Kirin Brewery Method for activation of human antigen-presenting cells, activated human antigen-presenting cells and use thereof
TW575420B (en) * 1997-09-22 2004-02-11 Kirin Brewery Composition for enhancing cellular immunogenicity comprising alpha-glycosylceramides
JP4787445B2 (ja) * 2000-01-14 2011-10-05 株式会社明治 抗原特異的ＩｇＥ抗体産生抑制剤
JP2002030093A (ja) * 2000-03-13 2002-01-29 Nof Corp グリコシルセラミドの精製方法
CA2459482C (fr) * 2001-08-16 2010-09-28 Daiichi Suntory Pharma Co., Ltd. Nouveau glycolipide et medicament pour le traitement de maladies auto-immunes contentant ce glycolipide en tant qu'ingredient actif
AU2003266530A1 (en) * 2002-09-20 2004-04-08 Kirin Beer Kabushiki Kaisha HEPATITIS C VIRUS INHIBITOR COMPRISING Alpha-GLYCOSYLCERAMIDE AS THE ACTIVE INGREDIENT
JP4585172B2 (ja) * 2003-01-31 2010-11-24 森永乳業株式会社 骨形成促進剤
EP1619199B1 (fr) * 2003-02-14 2013-12-18 Japan as represented by President of National Center of Neurology and Psychiatry Ministry of Health Derives de glycolipide, leur procede de production, intermediaires pour la synthese associee, et procede de production desdits intermediaires
JP4753089B2 (ja) * 2004-12-20 2011-08-17 株式会社岡安商店 体内脂肪の分解促進作用を有する組成物及びそれを含有する食品又は食品配合剤
JP2007070311A (ja) * 2005-09-09 2007-03-22 Gunma Univ α−ガラクトシルセラミドからなる感染症予防剤及び感染症治療剤
EP1776963A1 (fr) 2005-10-19 2007-04-25 Gbf-Gesellschaft Für Biotechnologische Forschung Mbh Hexosylcéramides comme adjuvants et leurs utilisations dans des compositions pharmaceutiques
WO2008047174A1 (fr) * 2006-10-18 2008-04-24 Centre National De La Recherche Scientifique Analogues de l'alpha-galactocéramide, leurs procédés de fabrication, composés intermédiaires utiles dans ces procédés, et compositions pharmaceutiques les contenant
KR100868959B1 (ko) * 2006-12-30 2008-11-17 재단법인서울대학교산학협력재단 알파-갈락토실세라마이드 유도체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는면역보조용 약학적 조성물
EP2117583B1 (fr) 2007-02-21 2013-05-22 Vib Vzw Thérapie combinatoire par TNF et alpha-galactosylcéramide
JP4995172B2 (ja) * 2008-10-10 2012-08-08 壽製薬株式会社 糖脂質誘導体、その製造方法並びにそれを有効成分とする医薬
AU2010213568B2 (en) 2009-02-16 2014-11-20 Cerenis Therapeutics Holding Sa Apolipoprotein A-I Mimics
JP5025692B2 (ja) * 2009-07-06 2012-09-12 壽製薬株式会社 糖脂質誘導体の製造方法
JP5095683B2 (ja) * 2009-07-06 2012-12-12 壽製薬株式会社 新規糖脂質誘導体及びこれを有効成分とする製剤
JP2010254718A (ja) * 2010-08-13 2010-11-11 Morinaga Milk Ind Co Ltd 骨形成促進剤
CN106167483B (zh) 2010-10-18 2019-02-15 塞伦尼斯医疗控股有限公司 可用于胆固醇动员的化合物、组合物和方法
EP2647384B1 (fr) 2010-12-02 2018-05-23 Riken IMMUNOTHÉRAPIE À L'AIDE DE CELLULES ALLO-NKT, CELLULES POUR IMMUNOTHÉRAPIE DANS LESQUELLES alpha CHAÎNE DU GÈNE DE RÉCEPTEUR DES LYMPHOCYTES T (TCR) A ÉTÉ RÉARRANGÉE EN UN V alpha-J alpha UNIFORME ET CONSTITUTION D'UNE BANQUE DE CELLULES NKT ISSUES DESDITES CELLULES
WO2014021464A1 (fr) * 2012-08-03 2014-02-06 独立行政法人理化学研究所 Analogue de krn7000 hydroxylé et son utilisation
EP2903622A1 (fr) 2012-10-03 2015-08-12 INSERM - Institut National de la Santé et de la Recherche Médicale Méthodes et compositions pharmaceutiques pour le traitement prophylactique des surinfections bactériennes post-grippales par des agonistes de cellules nkt invariants
JP6599233B2 (ja) 2012-11-21 2019-10-30 アンセルム（アンスティチュート・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシェルシュ・メディカル） 急性移植片対宿主病のリスクを決定する方法
WO2017207040A1 (fr) 2016-06-01 2017-12-07 Vib Vzw Thérapie anticancéreuse utilisant un antagoniste de la leptine et un activateur des cellules inkt
KR102328367B1 (ko) * 2019-11-05 2021-11-18 한국해양과학기술원 아젤록심 d를 유효성분으로 함유하는 방사선 민감성 증진용 조성물
EP4257140A4 (fr) 2020-12-04 2024-11-06 Regimmune Corporation Préparation de liposomes contenant un composé ligand cd1d présentant une pharmacocinétique améliorée

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6157594A (ja) * 1984-08-30 1986-03-24 Suntory Ltd ガラクトスフインゴ脂質及びその製造法
JP2588729B2 (ja) * 1987-10-05 1997-03-12 塩野義製薬株式会社 スフィンゴシン誘導体
DE3840044A1 (de) * 1988-11-27 1990-06-07 Behringwerke Ag Glykosphingolipide mit kopplungsfaehiger gruppe im sphingoidanteil, ihre herstellung und verwendung
JP3068910B2 (ja) * 1990-11-08 2000-07-24 麒麟麦酒株式会社 新規スフィンゴ糖脂質、その製造法および使用

Also Published As

Publication number Publication date
GR3030723T3 (en) 1999-11-30
DE69229557D1 (de) 1999-08-12
AU1666492A (en) 1993-04-05
HU223839B1 (hu) 2005-02-28
NO180338B (no) 1996-12-23
PT100736A (pt) 1993-09-30
TW197446B (fr) 1993-01-01
FI940851A7 (fi) 1994-02-23
KR100220793B1 (ko) 1999-10-01
WO1993005055A1 (fr) 1993-03-18
NO940598D0 (no) 1994-02-22
AU665536B2 (en) 1996-01-11
CA2116442A1 (fr) 1993-03-18
HU9400596D0 (en) 1994-05-30
EP0609437A4 (en) 1994-08-24
NO940598L (fr) 1994-04-27
DK0609437T3 (da) 2000-01-31
HK1009967A1 (en) 1999-09-17
FI940851A0 (fi) 1994-02-23
JP2774194B2 (ja) 1998-07-09
FI105189B (fi) 2000-06-30
ZA923239B (en) 1993-05-05
DE69229557T2 (de) 1999-11-25
EP0609437B1 (fr) 1999-07-07
EP0609437A1 (fr) 1994-08-10
NO180338C (no) 1997-04-02
ATE181922T1 (de) 1999-07-15
JPH0559081A (ja) 1993-03-09
CA2116442C (fr) 2000-09-05
PT100736B (pt) 1999-04-30
ES2134213T3 (es) 1999-10-01
HUT70435A (en) 1995-10-30

Similar Documents

Publication Publication Date Title
ZA923239B (en) Glycosphingolipids and the use thereof.
GR3034428T3 (en) Antifoaming agents.
HUT57043A (en) Process for producing pharmaceutical solutions comprising macrolide
EP1008342A3 (fr) Composés pharmaceutiquement actifs et liposomes, et leur application
CA2043071A1 (fr) Composes heterocycliques
EP0694558A4 (fr) Nouveau sphingoglycolipide et son utilisation
SG49607A1 (en) 1-methylcarbapenem derivatives and process for preparation thereof
HU912649D0 (en) New tricyclic compounds production threreof and anti-microbic preparatives
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
GB8826595D0 (en) Active compounds
DE3377213D1 (en) Novel cephalosporin compounds and preparation thereof
IL103826A0 (en) Thiazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
HUT54372A (en) Process for producing macrolide compounds and pharmaceutical compositions containing them as active components
TW350757B (en) Benzisoxazole derivatives and pesticidal compositions containing them
GB8908700D0 (en) Compounds
HUT49887A (en) Process for producing new cefem compounds
IE831349L (en) 4-aminopiperidine derivatives
EP0330025A3 (fr) Composition antidiabétique contenant des dérivés de l'isocarbacycline
GB9015485D0 (en) Heterocyclic derivatives
IL95377A0 (en) Therapeutic agent for the treatment of peptic ulcer disease containing xanthine derivatives and some novel compounds of this type
GR3027627T3 (en) New 17alpha-Cyanomethylestra-4,9-dien-derivatives, a process for the production of these compounds and pharmaceutical compositions containing them
HUT65417A (en) Process for producing pharmaceutical compositions for rectal administration containing triazole derivatives